CARE Ratings Ltd

CARE Ratings Ltd has announced the appointment of Mr. Sanjay Agarwal as the new Chief Risk Officer, effective August 1, 2026. Mr. Agarwal, a Chartered Accountant with over 30 years of experience in financial services, including 16 years with the company, brings extensive expertise in risk management, credit analysis, and financial research. His current role as Senior Director highlights his deep understanding of the company's operations and strategic direction.

CARE Ratings Limited has announced the closure of its trading window for dealing in the company's shares. This closure is effective from Wednesday, July 01, 2026, and will remain in effect until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for directors, rating committee members, and employees.

CARE Ratings Ltd has informed shareholders that it has sent a web-link to the Annual Report for FY2026 to members who have not registered their email addresses. The 33rd Annual General Meeting (AGM) is scheduled for July 3, 2026, via Video Conference. Electronic copies of the AGM notice and Annual Report have been sent to shareholders with registered emails. For those without registered emails, a physical letter provides a web-link to access the report online. Physical copies can be requested via email. Key dates for the AGM include the record date for dividend and e-voting on June 26, 2026, with e-voting closing on July 2, 2026, and dividend payment by August 1, 2026.

CARE Ratings Limited has released its Annual Report for the Financial Year 2025-26, along with the Notice for its 33rd Annual General Meeting (AGM). The AGM is scheduled for July 3, 2026, to be held via Video Conferencing. The report includes the Business Responsibility and Sustainability Report and details financial performance, operational highlights, and corporate governance. Key financial metrics for FY26 include Revenue from Operations at Rs. 473.07 crore (up 33%), EBITDA at Rs. 197.40 crore (up 27%), and PAT at Rs. 173.70 crore (up 18%). The company reported an EBITDA margin of 42% and a PAT margin of 33%, with an EPS of Rs. 57.06. The report emphasizes the company's strategy of navigating complex environments with clarity and conviction, expanding its global footprint, and investing in technology and talent.

CARE Ratings Limited has announced that its Thirty Third (33rd) Annual General Meeting (AGM) will be held on Friday, July 3, 2026, at 3:30 PM IST. The meeting will be conducted through Video Conferencing / Other Audio Visual Means (VC/OAVM). The company has also enclosed its Annual Report for the Financial Year 2025-26, including the Business Responsibility and Sustainability Report and the Notice convening the AGM. The Annual Report and AGM Notice have been sent electronically to members. The record date for dividend payment and eligibility for e-voting is June 26, 2026. E-voting will commence on June 30, 2026, and conclude on July 2, 2026.

CARE Ratings Ltd announced that the Hon'ble Madras High Court has vacated the injunction order dated February 1, 2023, which had restrained the company from alienating its assets. The injunction was lifted on June 3, 2026, after the company complied with the court's earlier order. This compliance was made without prejudice to the company's rights in its ongoing appeals. The company received the official order on June 4, 2026.

CARE Ratings Ltd has re-appointed B S R & Co. LLP as its Statutory Auditors for a term of five years, commencing from the conclusion of the 33rd Annual General Meeting (AGM) in 2026 until the conclusion of the 38th AGM in 2031. This re-appointment is subject to the approval of the shareholders at the upcoming AGM. The Board of Directors approved this decision at their meeting held on May 13, 2026.

CARE Ratings Ltd's board approved the audited standalone and consolidated financial results for FY26 and recommended a final dividend of ₹14 per equity share. The re-appointment of B S R & Co. LLP as Statutory Auditors for five years was also approved, subject to member approval at the AGM on July 3, 2026. Additionally, 55,000 stock options were granted to eligible employees under the 'CARE Employee Stock Option Scheme 2020'.

CARE Ratings Ltd's Board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹14 per equity share for FY26, subject to member approval, with a record date of June 26, 2026. B S R & Co. LLP was re-appointed as Statutory Auditors for five years, pending member approval. Additionally, 55,000 stock options were granted to eligible employees under the 'CARE Employee Stock Option Scheme 2020'. The 33rd Annual General Meeting will be held on July 3, 2026, via video conferencing.

CARE Ratings Ltd's board approved a final dividend of ₹14 per equity share (face value of ₹10) for FY26, pending shareholder approval. The record date for dividend payment is set for June 26, 2026. The board also approved the re-appointment of B S R & Co. LLP as statutory auditors for five years, starting from the conclusion of the 33rd AGM until the 38th AGM, subject to member approval. Additionally, 55,000 stock options were granted to eligible employees under the 'CARE Employee Stock Option Scheme 2020'. The 33rd Annual General Meeting will be held on July 3, 2026, via video conferencing.